Author:
Akiko Tanino,Okura Takafumi,Nagao Tomoaki,Kukida Masayoshi,Enomoto Daijiro,Miyoshi Ken-ichi,Higaki Jitsuo,Kuroda Masayuki,Bujo Hideaki
Funder
Pfizer Inc
Asteras Co
Takeda Pharm Co
Boehringer-Ingelheim Japan Co
Daiichi-Sankyo Co
MSD Co
Mochida Pharm Co
Novartis Pharm Co
DaiNihon-Sumitomo Co
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference17 articles.
1. Saeedi R, Li M, Frohlich J. A review on lecithin:cholesterol acyltransferase deficiency. Clin Biochem. 2015;48:472–5.
2. Norum KR, Gjone E. Familial plasma lecithin: cholesterol acyltransferase deficiency. Scand J Clin Invest. 1967;20:31–243.
3. Kunnen S, Van EM. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis. J Lipid Res. 2012;53:1783–99.
4. Maruyama T, Yamashita S, Matsuzawa Y, Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan, et al. Mutations in Japanese subjects with primary hyperlipidemia: results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996. J Atheroscler Thromb. 2004;11:131–45.
5. Katayama A, Wada J, Kataoka UH, et al. Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations. NDT Plus. 2011;4:299–302.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献